Wrap Text
Issue and Cancellation of Options and appendix 3B
Tawana Resources NL
(Incorporated in Australia)
(Registration number ACN 085 166 721)
Share code on the JSE Limited: TAW
JSE ISIN: AU0000TAWDA9
Share code on the Australian Securities Exchange Limited: TAW
ASX ISIN: AU000000TAW7
(“the Company” or “Tawana”)
Issue and Cancellation of Options and appendix 3B
Tawana Resources NL (ASX: TAW) advises that the following options have
respectively been issued and cancelled:
• Issue of 2,000,000 options; and
• Cancellation of 250,000 Options ($0.13, Exp. 07 January 2020);
Please refer to the Appendix 3B attached.
For further information please contact the Company Secretary, Claire O’Brien on
+61 8 9489 2600.
Yours faithfully
Claire O’Brien
Joint Company Secretary
Detailed information on all aspects of Tawana’s projects can be found on the
Company’s website www.tawana.com.au
22 December 2017
Sponsor
PricewaterhouseCoopers Corporate Finance (Pty) Ltd
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity
TAWANA RESOURCES NL
ABN
69 085 166 721
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued or to Director Options
be issued
2 Number of +securities issued or 2,000,000
to be issued (if known) or
maximum number which may be
issued
3 Principal terms of the +securities Director Options (ex. $0.20, exp. 20 December 2020)
(eg, if options, exercise price
and expiry date; if partly paid
+securities, the amount
outstanding and due dates for
payment; if +convertible
securities, the conversion price
and dates for conversion)
4 Do the +securities rank equally in
all respects from the date of No
allotment with an existing +class of
quoted +securities?
If the additional securities do not
rank equally, please state:
- the date from which they do
- the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest
payment
- the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5 Issue price or consideration Nil
6 Purpose of the issue N/A.
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
6a Is the entity an +eligible entity that No
has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i
6b The date the security holder N/A
resolution under rule 7.1A was
passed
6c Number of +securities issued N/A
without security holder approval
under rule 7.1
6d Number of +securities issued with N/A
security holder approval under rule
7.1A
6e Number of +securities issued with N/A
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f Number of securities issued under N/A
an exception in rule 7.2
6g If securities issued under rule N/A
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
issue date and both values. Include
the source of the VWAP
calculation.
6h If securities were issued under rule N/A
7.1A for non-cash consideration,
state date on which valuation of
consideration was released to ASX
Market Announcements
6i Calculate the entity’s remaining 7.1 – 75,026,757
issue capacity under rule 7.1 and 7.1A – N/A
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7 Dates of entering +securities into 20 December 2017
uncertificated holdings or despatch
of certificates
Number +Class
8 Number and +class of all 504,280,941 Ordinary Fully Paid
+securities quoted on ASX Shares
(including the securities in section
2 if applicable)
Number +Class
9 Number and +class of all 400,000 Class F Incentive Options
+securities not quoted on ASX ($0.178, 26 May 2018)
(including the securities in section 2,500,000 Class G Placement Options
2 if applicable) ($0.035, 14 June 2018)
3,000,000 Class H Incentive Options
($0.06, 30 June 2019)
1,000,000 Class I Incentive Options
($0.06, 30 June 2019)
2,000,000 Class J Incentive Options
($0.13, 7 January 2020)
1,500,000 Class L Incentive Options
($0.16, 15 March 2020)
620,000 Class M Incentive Options
($0.18, 8 May 2020)
500,000 Class N Incentive Options
($0.23, 27 March 2020)
3,000,000 Class O Corporate Advisor Options
($0.20, 12 April 2020)
3,000,000 Class P Corporate Advisor Options
($0.25, 12 April 2020)
3,000,000 Class Q Corporate Advisor Options
($0.30, 12 April 2020)
500,000 Director Options
($0.20, 15 June 2020)
8,000,000 Advisor Options
($0. 30625, 19 July 2020)
500,000 Class O Incentive Options, ($0.22, and
$0.24, 21 August 2020)
2,000,000 Director Options
($0.20, 20 December 2020)
10 Dividend policy (in the case of a Unchanged
trust, distribution policy) on the
increased capital (interests)
Part 2 - Bonus issue or pro rata issue
11 Is security holder approval N/A
required?
12 Is the issue renounceable or non- N/A
renounceable?
13 Ratio in which the +securities will N/A
be offered
14 +Class of +securities to which the N/A
offer relates
15 +Record date to determine N/A
entitlements
16 Will holdings on different registers N/A
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in N/A
relation to fractions
18 Names of countries in which the N/A
entity has +security holders who
will not be sent new issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt of N/A
acceptances or renunciations
20 Names of any underwriters N/A
21 Amount of any underwriting fee or N/A
commission
22 Names of any brokers to the issue N/A
23 Fee or commission payable to the N/A
broker to the issue
24 Amount of any handling fee payable N/A
to brokers who lodge acceptances
or renunciations on behalf of
+security holders
25 If the issue is contingent on N/A
+security holders’ approval, the date
of the meeting
26 Date entitlement and acceptance N/A
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and N/A
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if N/A
applicable)
29 Date rights trading will end (if N/A
applicable)
30 How do +security holders sell their N/A
entitlements in full through a
broker?
31 How do +security holders sell part N/A
of their entitlements through a
broker and accept for the balance?
32 How do +security holders dispose of N/A
their entitlements (except by sale
through a broker)?
33 +Issue date N/A
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities
(tick one)
(a) - Securities described in Part 1
(b) All other securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee
incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35 If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities held by
those holders
36 If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of securities for which
+quotation is sought
39 Class of +securities for which
quotation is sought
40 Do the +securities rank equally in all
respects from the date of allotment
with an existing +class of quoted
+securities?
If the additional securities do not
rank equally, please state:
- the date from which they do
- the extent to which they
participate for the next dividend,
(in the case of a trust,
distribution) or interest payment
- the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41 Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of
another security, clearly identify that
other security)
Number +Class
42 Number and +class
of all +securities
quoted on ASX (including the
securities in clause 38)
Quotation agreement
1 +Quotationof our additional +securities is in ASX’s absolute discretion. ASX may
quote the+securities
on any conditions it decides.
2 We warrant the following to ASX.
- The issue of the +securities to be quoted complies with the law and is not
for an illegal purpose.
- There is no reason why those +securities should not be granted +quotation.
- An offer of the +securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give
this warranty
- Section 724 or section 1016E of the Corporations Act does not apply to any
applications received by us in relation to any +securities to be quoted and
that no-one has any right to return any +securities to be quoted under
sections 737, 738 or 1016F of the Corporations Act at the time that we
request that the +securities be quoted.
- If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at the
time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.
4 We give ASX the information and documents required by this form. If any
information or document not available now, will give it to ASX before +quotation
of the +securities begins. We acknowledge that ASX is relying on the information
and documents. We warrant that they are (will be) true and complete.
Sign here: ................... ........................ …. Date: 22 December 2017
(Company secretary)
Print name: Claire O’Brien
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for
+eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid ordinary 294,654,327
securities on issue 12 months before date
of issue or agreement to issue
Add the following: 27,200,175 (approved at shareholder meeting
dated 23 December 2016)
• Number of fully paid ordinary securities
issued in that 12 month period under 50,000,000 (approved at shareholder meeting
dated 23 December 2016)
an exception in rule 7.2
3,171,000 (approved at shareholder meeting
• Number of fully paid ordinary securities dated 23 December 2016)
issued in that 12 month period with
shareholder approval 7,092,198 Shares (ratified at shareholder
meeting dated 23 May 2017)
• Number of partly paid ordinary
securities that became fully paid in that 35,900,000 (ratified at shareholder meeting
12 month period dated 6 June 2017)
Note: 24,100,000 (approved at shareholder meeting
• Include only ordinary securities here – dated 6 June 2017)
other classes of equity securities
cannot be added 3,405,000 (exercise of options on 1 November
2017)
• Include here (if applicable) the
securities the subject of the Appendix
1,000,000 (exercise of options on 20 November
3B to which this form is annexed 2017)
• It may be useful to set out issues of
securities on different dates as 14,285,714 (ratified at shareholder meeting
separate line items dated 12 December 2017)
42,857,143 (ratified at shareholder meeting
dated 12 December 2017)
Subtract the number of fully paid ordinary -
securities cancelled during that 12 month
period
“A”
503,665,557
+ See chapter 19 for defined terms.
01/08/2012 Appendix 3B Page 13
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 75,549,834
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of equity securities issued or
615,384 Fully Paid Ordinary Shares (Issued
agreed to be issued in that 12 month period
06/11/2017)
not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C” 615,384
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 75,549,834
Note: number must be same as shown in
Step 2
Subtract “C” 615,384
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C” 74,934,450
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A” Not Applicable
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of equity securities issued or
agreed to be issued in that 12 month period
under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
+ See chapter 19 for defined terms.
01/08/2012 Appendix 3B Page 15
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
Subtract “E”
Note: number must be same as shown in
Step 3
Total [“A” x 0.10] – “E” Note: this is the remaining placement
capacity under rule 7.1A
Date: 22/12/2017 09:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
